Added to YB: 2019-01-10
Pitch date: 2019-01-10
RGNX [bullish]
REGENXBIO Inc.
-69.73%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapies that deliver functional genes to cells with genetic defects in the United States.
Market Cap
$437.4M
Pitch Price
$45.82
Price Target
N/A
Dividend
N/A
EV/EBITDA
-2.33
P/E
-2.80
EV/Sales
1.90
Sector
Biotechnology
Category
N/A
Show full summary:
REGENXBIO INC RGNX
A summary for this pitch has not been created yet.
Read full article (0 min)